JTCS Sign the Guestbook
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Ara A. Vaporciyan
David C. Rice
Jack A. Roth
Stephen G. Swisher
Garrett L. Walsh
Joe B. Putnam, Jr
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Vaporciyan, A. A.
Right arrow Articles by Putnam, J. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Vaporciyan, A. A.
Right arrow Articles by Putnam, J. B., Jr
Related Collections
Right arrowRelated Article

J Thorac Cardiovasc Surg 2004;127:779-786
© 2004 The American Association for Thoracic Surgery


Cardiopulmonary support and physiology

Risk factors associated with atrial fibrillation after noncardiac thoracic surgery: analysis of 2588 patients

Ara A. Vaporciyan, MDa,*, Arlene M. Correa, PhDa, David C. Rice, MDa, Jack A. Roth, MDa, W. R. Smythe, MDa, Stephen G. Swisher, MDa, Garrett L. Walsh, MDa, Joe B. Putnam, Jr, MDa

a Department of Thoracic and Cardiovascular Surgery, The University of Texas M. D. Anderson Cancer Center, Houston, Tex, USA

Received for publication May 1, 2003; revisions received June 23, 2003; revisions received July 14, 2003; accepted for publication July 31, 2003.

* Address for reprints: Ara A. Vaporciyan, MD, M. D. Anderson Cancer Center, 1515 Holcombe Blvd, Box 445, Houston, TX 77030, USA
avaporci{at}mdanderson.org

OBJECTIVE: The purpose of this study was to identify risk factors associated with the onset of atrial fibrillation after thoracic surgery to allow more targeted interventions in patients with the highest risk.

METHODS: A comprehensive prospective database was used to identify patients undergoing major thoracic surgery from January 1, 1998, through December 31, 2002. Data collection was performed at point of contact: at preoperative evaluation, the time of the operation, discharge, and postoperative visits. All patients undergoing resection of a lung, the esophagus, the chest wall, or a mediastinal mass were included in this study. Univariate and multivariate analyses of factors associated with the development of atrial fibrillation were analyzed.

RESULTS: There were 2588 patients who met the inclusion criteria. The overall incidence of atrial fibrillation was 12.3% (n = 319). Categories of disease were primary lung cancer, pulmonary metastasis, esophageal cancer, intrathoracic metastasis, benign lung disease, other mediastinal tumors, mesothelioma, chest wall tumors, benign esophagus, and "other." Patients with atrial fibrillation had increased mean lengths of hospital stay, mortality rates, and mean hospital charges. Univariate analysis evaluated age, sex, disease category, comorbidities, preoperative therapy, and procedure, and significant variables were entered into the multivariate analysis. Significant variables (relative risk; 95% confidence interval) in the multivariate analysis were male sex (1.72; 1.29-2.28), age 50 to 59 years (1.70; 1.01-2.88), age 60 to 69 years (4.49; 2.79-7.22), age 70 years or greater (5.30; 3.28-8.59), history of congestive heart failure (2.51; 1.06-6.24), history of arrhythmias (1.92; 1.22-3.02), history of peripheral vascular disease (1.65; 0.93-2.92), resection of mediastinal tumor or thymectomy (2.36; 0.95-5.88), lobectomy (3.89; 2.19-6.91), bilobectomy (7.16; 3.02-16.96), pneumonectomy (8.91; 4.59-17.28), esophagectomy (2.95; 1.55-5.62), and intraoperative transfusions (1.39; 0.98-1.98).

CONCLUSIONS: The significant variables identified by means of multivariate analysis were associated with the occurrence of atrial fibrillation. Preventive therapies in selected populations might reduce the incidence of atrial fibrillation.



Related Article

The problem of atrial arrhythmias after noncardiac thoracic surgery
Lawrence L. Creswell
J. Thorac. Cardiovasc. Surg. 2004 127: 629-630. [Extract] [Full Text] [PDF]



This article has been cited by other articles:


Home page
Eur. J. Cardiothorac. Surg.Home page
C. Materazzo, P. Piotti, C. Mantovani, R. Miceli, and F. Villani
Atrial fibrillation after non-cardiac surgery: P-wave characteristics and Holter monitoring in risk assessment
Eur. J. Cardiothorac. Surg., May 1, 2007; 31(5): 812 - 816.
[Abstract] [Full Text] [PDF]


Home page
ICVTSHome page
B. Hoksch, R. Fahrner, and R. Alexander Schmid
Procalcitonin and brain natriuretic peptide as parameters in the postoperative course of patients with major pulmonary resection
Interactive CardioVascular and Thoracic Surgery, April 1, 2007; 6(2): 155 - 159.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
D. Cardinale, A. Colombo, M. T. Sandri, G. Lamantia, N. Colombo, M. Civelli, M. Salvatici, G. Veronesi, F. Veglia, C. Fiorentini, et al.
Increased Perioperative N-Terminal Pro-B-Type Natriuretic Peptide Levels Predict Atrial Fibrillation After Thoracic Surgery for Lung Cancer
Circulation, March 20, 2007; 115(11): 1339 - 1344.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
B. J. Park, H. Zhang, V. W. Rusch, and D. Amar
Video-assisted thoracic surgery does not reduce the incidence of postoperative atrial fibrillation after pulmonary lobectomy
J. Thorac. Cardiovasc. Surg., March 1, 2007; 133(3): 775 - 779.
[Abstract] [Full Text] [PDF]


Home page
Eur. J. Cardiothorac. Surg.Home page
A. Bobbio, D. Caporale, E. Internullo, L. Ampollini, S. Bettati, E. Rossini, P. Carbognani, and M. Rusca
Postoperative outcome of patients undergoing lung resection presenting with new-onset atrial fibrillation managed by amiodarone or diltiazem
Eur. J. Cardiothorac. Surg., January 1, 2007; 31(1): 70 - 74.
[Abstract] [Full Text] [PDF]


Home page
Eur. J. Cardiothorac. Surg.Home page
I. Opitz, P. Kestenholz, D. Lardinois, M. Muller, V. Rousson, D. Schneiter, R. Stahel, and W. Weder
Incidence and management of complications after neoadjuvant chemotherapy followed by extrapleural pneumonectomy for malignant pleural mesothelioma.
Eur. J. Cardiothorac. Surg., April 1, 2006; 29(4): 579 - 584.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
E. E. Roselli, S. C. Murthy, T. W. Rice, P. L. Houghtaling, C. D. Pierce, D. P. Karchmer, and E. H. Blackstone
Atrial fibrillation complicating lung cancer resection
J. Thorac. Cardiovasc. Surg., August 1, 2005; 130(2): 438 - 444.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
R. S. Passman, D. S. Gingold, D. Amar, D. Lloyd-Jones, C. L. Bennett, H. Zhang, and V. W. Rusch
Prediction Rule for Atrial Fibrillation After Major Noncardiac Thoracic Surgery
Ann. Thorac. Surg., May 1, 2005; 79(5): 1698 - 1703.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
D. C. Rice, A. M. Correa, A. A. Vaporciyan, N. Sodhi, W. R. Smythe, S. G. Swisher, G. L. Walsh, J. B. Putnam Jr, R. Komaki, J. A. Ajani, et al.
Preoperative Chemoradiotherapy Prior to Esophagectomy in Elderly Patients is Not Associated With Increased Morbidity
Ann. Thorac. Surg., February 1, 2005; 79(2): 391 - 397.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 2004 by The American Association for Thoracic Surgery.